Diabetic retinopathy disease

https://doi.org/10.53730/ijhs.v6nS2.5042

Authors

  • Aditya Subhash Pachpute MBBS 1ST Year Student at Datta Meghe Medical College,Nagpur, India
  • Rakesh Kumar Jha Tutor Dept. of Biochemistry Datta Meghe Medical College, Shalinitai Meghe Hospital and Research Centre Nagpur, India
  • Karuna Kachawa Assistant Professor Dept. of Biochemistry Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences Sawangi (Meghe) Wardha, India

Keywords:

diabetic retinopathy, eye examination, fluroescein angiography, maculopathy, non proliferative, proliferative diabetic retinopathy, VEGF, vitreoretinal surgery

Abstract

INTRODUCTION: Diabetic Retinopathy is an eye disease that can cause loss of vision and vision in people with diabetes. Diabetic retinopathy occurs when high blood sugar levels affect the blood vessels in the retina. Nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) are two types of diabetic retinopathy (PDR). Blood sugar levels may be controlled to control NPDR. PDR is a very serious condition that affects the middle view. Diabetes retinopathy is diagnosed using dilated eye scan, fluorescein angiography, and optical coherence tomography. Laser treatments, eye injections, and surgery are also used to treat the onset of diabetes. To prevent new blood vessels from growing behind the eyes, injections of vascular endothelial cell factor inhibitors are injected directly into the eyes. AIM: Diabetic retinopathy disease. CONCLUSION: Diabetic retinopathy is a permanent condition. Laser analysis (photocoagulation) is normally very helpful at avoiding vision damage when performed before the eye is damaged. If the eye is not badly affected, surgical removal of the vitreous gel will increase vision (vitrectomy). An anti-inflammatory or anti-vascular endothelial growth factor injection may help create new blood vessels in some cases of chronic diabetes.

Downloads

Download data is not yet available.

References

Guidelines for Diabetic Retinopathy Management. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/di15.pdf.

Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O'Neal DN, Januszewski AS. Biomarkers in Diabetic Retinopathy. Rev Diabet Stud. 2015;12(1-2):159-195. doi:10.1900/RDS.2015.12.159

Kowluru RA, Kowluru A, Mishra M, Kumar B. Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res. 2015; 48:40-61. doi:10.1016/j.preteyeres.2015.05.001

National Diabetes Statistics Report. Estimates of diabetes and its burden in the United States, 2014.Atlanta, GA: U.S. Department of Health and Human Services; 2014 [Google Scholar]

2. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology 2003;110:1952–1959.

Lawrence JM, Contreras R, Chen W, Sacks DA, the New England Journal of Medicine, 2008; 356 (15):1499–501.

Diabetic Retinopathy Stages: The 4 Stages and What to Do (healthline.com)

Diabetic retinopathy: Causes, symptoms, and treatments (medicalnewstoday.com)

Shah, A.R., Gardner, T.W. Diabetic retinopathy: research to clinical practice. Clin Diabetes Endocrinol 3, 9 (2017). https://doi.org/10.1186/s40842-017-0047-y

Published

24-03-2022

How to Cite

Pachpute, A. S., Jha, R. K., & Kachawa, K. (2022). Diabetic retinopathy disease. International Journal of Health Sciences, 6(S2), 481–487. https://doi.org/10.53730/ijhs.v6nS2.5042

Issue

Section

Peer Review Articles